RPL554: the potential

RPL554 for COPD   |   Runtime: 02:24

Verona Pharma's RPL554 has the potential to address airflow obstruction and persistent inflammation in COPD patients.

 

COPD: a beacon of hope

COPD: a beacon of hope

Verona Pharma can make a real difference to the COPD market believes CEO Jan-Anders Karlsson

Verona Pharma can make a real difference to the COPD market believes CEO Jan-Anders Karlsson

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us